|
HOVIONE
Founded in 1959, the Hovione Group employs 650 staff of which 19% are involved in process chemistry R&D. Hovione is exclusively dedicated to the synthesis of API’s and regulated intermediates. We provide a complete solution from drug process development and scale-up at our NJ Technology Transfer Centre (TTC) to post-launch commercial manufacture at two sites, Loures, Portugal and Macau.
Contact information:
|
